TABLE 1.

Antibiotic susceptibilities of Acinetobacter species isolates

Strain	Source	AMK	CFZ	FEP	CRO	CIP	CLI	IPM	GEN	LVX	MEM	MXF	TZP	TGC	SXT
AB004	Winnipeg, MB	32	>128	128	32	2	2	0.25	32	1	2	0.5	64	2	0.12
AB005	Winnipeg, MB	<1	128	≤1	≤1	≤0.06	1	0.25	≤0.5	0.12	0.25	≤0.06	≤1	0.5	≤0.12
AB006	Vancouver, BC	2	>128	4	16	0.5	2	0.25	2	0.25	1	0.25	8	1	≤0.12
AB007	Vancouver, BC	2	>128	8	8	1	1	0.25	1	0.25	0.5	0.12	16	0.5	0.5
AB008	Hamilton, ON	2	>128	2	4	0.12	1	0.25	0.5	≤0.06	0.5	≤0.06	≤1	0.5	0.25
AB009	Hamilton, ON	2	>128	2	8	0.5	0.5	0.25	0.5	0.12	0.5	0.12	≤1	0.5	0.25
AB010	Vancouver, BC	2	>128	4	16	0.5	1	0.25	1	0.25	1	0.12	8	0.5	>8
AB011	Winnipeg, MB	32	>128	64	16	2	2	0.5	32	0.5	2	0.5	32	2	≤0.12
AB012	Victoria, BC	2	>128	2	16	0.12	1	0.12	0.5	0.12	0.5	≤0.06	4	0.25	≤0.12
AB013	Vancouver, BC	16	128	16	16	1	1	0.25	32	0.5	1	0.5	≤1	2	≤0.12
AB014	Montreal, QC	2	>128	8	16	0.5	0.25	0.25	≤0.25	0.25	1	0.12	16	0.5	0.25
AB027	Montreal, QC	>64	>128	>128	>256	>16	1	32	32	16	16	8	>512	4	>8
AB028	Winnipeg, MB	2	>28	32	64	>16	0.5	0.25	>32	16	2	8	128	0.5	8
AB029	Winnipeg, MB	≤1	128	16	2	2	0.5	0.25	≤0.5	1	0.5	0.5	≤1	2	≤0.12
AB030	Winnipeg, MB	64	>128	>64	>64	>16	0.5	>32	>32	16	>32	>16	>512	>16	>8
AB031	Toronto, ON	2	>128	4	16	0.25	0.5	0.25	<0.5	0.25	1	0.12	4	8	4
ATCC19606	ATCC	8	128	16	32	1	1	0.25	8	0.5	1	0.5	4	1	8

Data expressed as μg/mL. AMK Amikacin; ATCC American Type Culture Collection; BC British Columbia; CFZ Cefazolin; CIP Ciprofloxacin; CLI Colistin; CRO Ceftriaxone; FEP Cefepime; GEN Gentamicin; IPM Imipenem; LVX Levofloxacin; MB Manitoba; MEM Meropenem; MXF Moxifloxacin; ON Ontario; QC Quebec; SXT trimethoprim/sulfamethoxazole; TGC Tigecycline; TZP Piperacillin-tazobactam